References
- Kannel W B, Daniel L, McGee PhD. Diabetes and Cardiovascular Disease. The Framingham Study. JAMA 1979; 241: 2035–8
- Fuller J H, Shripley M J, Rose G, Jarrett R J, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J 1983; 287: 867–70
- Jarrett R J, McCartney P, Keen H. The Bedford Survey: Ten Year Mortality Rates in Newly Diagnosed Diabetics, Borderline Diabetics and Normo-glycaemic Controls and Risk Indicides for Coronary Heart Disease in Borderline Diabetics. Diabetologia 1982; 22: 79–84
- Barrett-Connor E, Wingard D L. Sex differential in ischemic heart disease mortality in diabetics: A prospective population-based study. Am J Epidemiol 1983; 118: 489–96
- Krolewski A S, Kolinski E J, Warren J H. Magnitude and determinants of coronary artery disease in juvenile-onset insulin-dependent diabetes Mellitus. Am J Cardiol 1987; 59: 750–5
- Borch-Johnsen K, Kragh Andersen P, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes Mellitus. Dia-betologia 1985; 28: 590–6
- Jarrett R J, Viberti G C, Argyropoulos A, Hill R D, Mahmud U, Murrells T J. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1984; 1: 17–9
- Haaber A B, Kofoed-Enevoldsen A, Jensen T. The prevalence of hypercholesterolaemia and its relationship with albuminuria in insulin-dependent diabetic patients: An epidemiological study. Diabetic Med 1992; 9: 557–61
- Jones S L, Close C F, Mattock M B, Jarrett R J, Keen H, Viberti G C. Plasma lipid and coagulation factor concentration in insulin-dependent diabetics with microalbuminuria. Br Med J 1989; 298: 487–90
- Jensen T, Stender S, Deckert T. Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabeto-logia 1988; 31: 142–5
- Chan M K, Persaud J W, Ramdial L, Varghese Z, Sweny P, Moorhead J F. Hyperlipidemia in untreated nephrotic syndrome, increased production or decreased removal?. Clin Chim Acta 1981; 117: 317–23
- Ohta T, Matsuda I. Lipid and apolipoprotein levels in patients with nephrotis syndrome. Clin Chem Acta 1981; 117: 133–43
- Gherardi E, Vecchia L, Calandra S. Experimental nephrotic syndrome in the rat induced by puro-mycin aminonucleoside. Exp Mol Pathol 1980; 32: 128–35
- Short C D, Durrington P N, Mallick N P, Hunt L P, Tetlow L, Ishola M. Serum and urinary high density lipoproteins in glomerular disease with proteinuria. Kidney Int 1986; 29: 1224–8
- Jüngst D, Caselmann W H, Kutschera P, Weiswei-Ler P. Relation of hyperlipidemia in serum and loss of high density lipoproteins in urine in the nephrotic syndrome. Clin Chim Acta 1987; 168: 159–67
- Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immuno assay-an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985; 45: 539–44
- Svendsen P AI, Christiansen J S, Seegaard U, Welinder B A, Nerup J. Rapid change in chromato-graphically determined haemoglobin A1c induced by short-term changes in glucose concentration. Diabetologia 1980; 19: 130–6
- Larsen K. Creatinine assay by reaction-kinetic principle. Clin Chem Acta 1972; 41: 130–6
- Friedewald W T, Levy R I, Frederickson D S. Estimation of the concentration of low-density cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
- Thompson J N, Erdody P, Brien R, Murray T K. Fluorometric determination of vitamin A in human blood and liver. Biochem. Med. 1971; 5: 67–89
- Morris M D, Zilversmit D B, Hintz H F. Hyperlipoproteinemia in fasting ponies. J Lipid Res 1972; 13: 383–9
- Joven J, Villabona C, Vilella E, Masana L, Alberti R, Valles M. Abnormalities of lipoprotein metabolism in patients with nephrotic syndrome. N Engl Med 1990; 323: 579–84
- Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M. Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int. 1988; 33: 100–6
- Golper T A, Swartz S H. Impaired renal mevalonate metabolism in nephrotic syndrome: A stimulus for increased hepatic cholesterogenesis independent of GFR and hypoalbuminuria. Metabolism 1982; 31: 471–6
- Warwick G L, Caslake M J, Boulton-Jones J M, Dagen M, Packard C J, Shepherd J. Low-density lipoprotein metabolism in the nephrotic syndrome. Metabolism 1990; 39: 187–92
- Appel G. Lipid abnormalities in renal disease. Kidney Int. 1991; 39: 169–83